Michael Scolaro

Michael Scolaro

Sep 19, 2017

Group 6 Copy 146
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we noninvasively measure blood sugar for diabetes?

    Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

    Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

    Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop a...

    Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

    If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

    Backer Badge Funded